Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...
Mediafeed on MSN
The reverse aging diet: What science shows (& how to do it)
This article was reviewed by Darragh O’Carroll, MD. Is There a Diet to Reverse Biological Age? What Science Shows (and How to ...
XRP finds renewed investor interest and whale accumulation worth $768 million but struggles to reclaim $2.50 resistance.
Today, protein-fortified foods and protein supplements form a market worth tens of billions of US dollars, with fitness ...
Regarding intraday stocks for today, Vaishali Parekh of Prabhudas Lilladher recommends three stocks to buy: Natco Pharma, ...
The Indian stock market closed strong on Wednesday, with the Sensex up 595 points. Key factors included optimism from trade ...
Stuck in a progress rut? Your big daily protein shake may be to blame! Try the “protein pacing” method—proven to enhance ...
Live for the Outdoors on MSN
Suunto Run watch review: Decent performance for an unbelievable price – so what’s the catch?
The Suunto Run watch offers an AMOLED screen, multi-band GPS and a huge range of training features for less than £200. But it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback